RAP 0.00% 20.5¢ resapp health limited

Ann: Update on US FDA De Novo Classification Request, page-57

  1. 31 Posts.
    lightbulb Created with Sketch. 32
    The share price will bounce back later this month when the deal is signed with the aussie telehealth company and then europe and china, USA is too risk adverse apparently, too worried of being sued
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.